rs4986933
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_005236.3(ERCC4):c.2579C>A(p.Ala860Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000475 in 1,614,134 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005236.3 missense
Scores
Clinical Significance
Conservation
Publications
- xeroderma pigmentosum group FInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, ClinGen
- Fanconi anemia complementation group QInheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- XFE progeroid syndromeInheritance: AR Classification: STRONG Submitted by: Ambry Genetics
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosumInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosum-Cockayne syndrome complexInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERCC4 | NM_005236.3 | c.2579C>A | p.Ala860Asp | missense_variant | Exon 11 of 11 | ENST00000311895.8 | NP_005227.1 | |
ERCC4 | XM_011522424.4 | c.2717C>A | p.Ala906Asp | missense_variant | Exon 12 of 12 | XP_011520726.1 | ||
ERCC4 | XM_047433774.1 | c.1790C>A | p.Ala597Asp | missense_variant | Exon 8 of 8 | XP_047289730.1 | ||
ERCC4 | XM_011522427.2 | c.1229C>A | p.Ala410Asp | missense_variant | Exon 6 of 6 | XP_011520729.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00227 AC: 346AN: 152128Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000692 AC: 174AN: 251432 AF XY: 0.000603 show subpopulations
GnomAD4 exome AF: 0.000284 AC: 415AN: 1461888Hom.: 1 Cov.: 33 AF XY: 0.000265 AC XY: 193AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00231 AC: 352AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.00251 AC XY: 187AN XY: 74428 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Xeroderma pigmentosum, group F Benign:3
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
- -
- -
not specified Benign:1Other:1
- -
- -
Xeroderma pigmentosum Uncertain:1
- -
Hutchinson-Gilford syndrome Uncertain:1
- -
Cockayne syndrome;C0268140:Xeroderma pigmentosum, group F;C3808988:Fanconi anemia complementation group Q Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
- -
Hereditary cancer-predisposing syndrome Benign:1
BA1, BP4 c.2579C>A, located in exon 11 of the ERCC4 gene, is predicted to result in the substitution of Alanine by Aspartic acid at codon 860, p.(Ala860Asp). The variant allele was found in 183/23610 alleles, with a filtering allele frequency of 0.7% at 95% confidence, within the African population in the gnomAD v2.1.1 database (non-cancer data set) (BA1). The SpliceAI algorithm predicts no significant impact on splicing. The REVEL meta-predictor score for this variant (0.218) suggests that it does not affect the protein function according Pejaver 2022 thresholds (PMID: 36413997) (BP4). To our knowledge, neither clinical data nor functional studies have been reported for this variant. It has been reported in ClinVar (2x uncertain significance, 6x likely benign). Based on currently available information, c.2579C>A is classified as a benign variant according to ACMG guidelines. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at